Home/ Supplements/ Iron/ NuFera

NuFera

product on market Tablet or Pill Carwin Pharmaceutical Associates Safety: 60/100
60/100

Review before taking

  • Carbonyl Iron: 125mg is 2.8× the Tolerable Upper Intake Level (45mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Carbonyl iron is used to support iron levels in the body, with strong evidence supporting its role in treating iron deficiency. However, the safety score of 60 indicates potential concerns regarding toxicity or adverse effects if not monitored. Evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Carbonyl Iron: 125mg is 2.8× the Tolerable Upper Intake Level (45mg)

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains 125mg of Carbonyl Iron, which is nearly three times the recommended maximum daily limit.

Label

Product Label

Label for NuFera
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Mineral
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

125 mg
Exceeds UL by 2.8× (UL: 45 mg) 505 studies (A:17, B:273)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: One tablet daily with or without food, or as prescribed by your healthcare provider.

Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age.

Keep this and all medications out of the reach of children.

Keep this and all medications out of the reach of children.

Tamper Evident: Do not use if seal is broken or missing.

Formulation Notes

Made in Canada

125 mg Carbonyl Iron

Additional Information

Storage: Store at 20 degrees - 25 degrees Celsius (68 degrees - 77 degrees Fahrenheit); excursions permitted to 15 degrees - 30 degrees Celsius (59 degrees - 86 degrees Fahrenheit) [see USP]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined by the USP using a child-resistant closure.

15370-265-30

Rx

See attached labeling for complete product information.

Metadata

Product Details

UPC / SKU3 15370 26530 1
DSLD Entry Date2021-11-19
Product TypeMineral
FormTablet or Pill
DSLD ID263321
Data Updated2026-04-11
Research

Research Evidence

566
Research Sources
56
Avg Quality
240
Meta Analysis
100
Clinical Trial
74
Systematic Review
71
Guideline
58
Rct
11
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
1
Observational
1
Openfda Safety
A Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Meta Analysis Nature medicine 2025 PubMed DOI
A Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Serum or plasma ferritin concentration as an index of iron deficiency and overload
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Non-invasive diagnostic tests for Helicobacter pylori infection
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
A Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Fortification of condiments and seasonings with iron for preventing anaemia and improving health
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
A Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2024 PubMed DOI
A Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic review
Meta Analysis Neuroscience and biobehavioral reviews 2025 PubMed DOI
View all evidence for Iron →
Compare

Similar Products

View all Iron products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.